3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
34
Rectal Neoplasms
22
Stomach Neoplasms
17
Triple Negative Breast Neoplasms
16
Colorectal Neoplasms
14
Neoplasm Metastasis
10
Adenocarcinoma
9
Pancreatic Neoplasms
8
Esophageal Neoplasms
8
Adenocarcinoma Of Esophagus
7
Neoplasms
5
Nasopharyngeal Carcinoma
5
Biliary Tract Neoplasms
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Colonic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Locally Advanced Rectal Cancer
2
Carcinoma
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Resectable Colon Cancer
1
Rectal Cancer Patients
1
Peritoneal Neoplasms
1
Interventions
Cyclophosphamide
26
fludarabine
18
Dexamethasone
17
pembrolizumab
12
Rituximab
11
Etoposide
10
venetoclax
9
pomalidomide
9
Gemcitabine
9
fludarabine phosphate
7
daratumumab
7
Lenalidomide
7
Bortezomib
7
carfilzomib
6
obinutuzumab
5
glofitamab
5
Vincristine
5
Temozolomide
5
Prednisone
5
Nivolumab
5
Immunotherapy, Adoptive
5
Cisplatin
5
Calcium Dobesilate
5
selinexor
4
cemiplimab
4
Doxorubicin
4
Cytarabine
4
Carboplatin
4
zanubrutinib
3
ruxolitinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Capecitabine
×
90 days
×
Clear all
No trials found.